Olga Lyass

Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2

Tamar Safra, Franco M. Muggia, Susan Jeffers et al. · Annals of Oncology · 2000 · 613 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma

Olga Lyass, Beatrice Uziely, Rami Ben‐Yosef et al. · Cancer · 2000 · 388 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy

Michael J. Zeléfsky, D. Crean, G Mageras et al. · Radiotherapy and Oncology · 1999 · 243 citations

Medicine, Radiation Oncology, Urology +16

Skin Toxic Effects of Polyethylene Glycol–Coated Liposomal Doxorubicin

Michal Lotem, Ayala Hubert, Olga Lyass et al. · Archives of Dermatology · 2000 · 220 citations

Medicine, Oncology, Pharmacology +17

Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes

Zvi Symon, Amos Peyser, Dinah Tzemach et al. · Cancer · 1999 · 210 citations

Medicine, Oncology, Pharmacology +16